As of 3:48:58 PM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.39M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SAMSARA BIOCAPITAL GP, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 24.91 - 27.50 per share. | Indirect | 1,259,623 | Nov 26, 2024 |
| CVIJIC CHRISTINE MIKAIL President | Purchase at price 20.48 per share. | Direct | 491,400 | Nov 22, 2024 |
| MCMINN RACHEL L. PH.D. Chief Executive Officer | Purchase at price 20.40 per share. | Direct | 969,000 | Nov 22, 2024 |
| CVIJIC CHRISTINE MIKAIL President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| COBB STUART Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Oct 5, 2023 |
| BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.63 - 0.69 per share. | Indirect | 1,463,487 | Aug 17, 2023 |
| SMITH SEAN MICHAEL Chief Financial Officer | Sale at price 0.62 per share. | Direct | 818 | Aug 11, 2023 |
| SMITH SEAN MICHAEL Chief Financial Officer | -- | Direct | -- | Aug 10, 2023 |
| PATEL PRITI Former | Sale at price 0.69 per share. | Direct | 2,608 | Apr 3, 2023 |
| PATEL PRITI Former | -- | Direct | -- | Mar 31, 2023 |
| PATEL PRITI Officer | Sale at price 0.60 per share. | Direct | 8,588 | Feb 2, 2023 |
| SMITH SEAN MICHAEL Officer | Sale at price 0.60 per share. | Direct | 1,980 | Feb 2, 2023 |
| PATEL PRITI Officer | -- | Direct | -- | Feb 1, 2023 |
| SMITH SEAN MICHAEL Officer | -- | Direct | -- | Feb 1, 2023 |
Related Tickers
RAPP Rapport Therapeutics, Inc.
14.50
-13.12%
TSHA Taysha Gene Therapies, Inc.
1.7450
-9.59%
THRD Third Harmonic Bio, Inc.
8.18
-24.19%
IGMS IGM Biosciences, Inc.
2.1450
-65.40%
KROS Keros Therapeutics, Inc.
14.66
-1.58%
AVBP ArriVent BioPharma, Inc.
24.74
-7.89%
STOK Stoke Therapeutics, Inc.
8.97
+0.11%
DYN Dyne Therapeutics, Inc.
15.90
-31.02%
VRCA Verrica Pharmaceuticals Inc.
0.6663
-4.77%
PRTA Prothena Corporation plc
13.12
-7.37%